Amsterdam-based Corbion and US-based biotech firm, Kuehnle AgroSystems (KAS) have entered into a strategic partnership to develop and commercialize a high-quality, natural astaxanthin derived from non-GMO heterotrophic algae.
Astaxanthin is a powerful antioxidant and red-orange carotenoid pigment found in various aquatic organisms, including microalgae, salmon, and shrimp. It is widely recognized both for its human health benefits and as a key feed ingredient for salmon and other aquaculture species.
Currently, most commercially available astaxanthin is either chemically synthesized for aquaculture use or derived from the phototrophic microalgae, Haematococcus for human health applications.
Corbion and KAS aim to provide a natural, algae-derived alternative produced through controlled fermentation of non-GMO, heterotrophic Haematococcus, the primary natural source of astaxanthin.
The partnership will focus on developing an esterified form of astaxanthin, rich in the most bioavailable isomer, delivering superior antioxidant performance, enhanced stability, and fat solubility. Designed for both the human and animal nutrition markets, the product is particularly well-suited for nutraceuticals and aquaculture applications.
By combining KAS’s advanced fermentation platform and proprietary non-GMO algae strains with Corbion’s industrial production capabilities, regulatory and go-to-market expertise, the 2 companies aim to scale up production to meet future market demand for clean-label ingredient.
